Atlas Trials

Phase 1b/2 Trial of AMG386 With Pemetrexed and Carboplatin in Non-Small Cell Lung Cancer

Clinical trial NCT01666977 · COMPLETED

Trial details

NCT number
NCT01666977
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Non Small Cell Lung Cancer
Start date
2012-08-01
Primary completion
2015-11-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.